DD202152A5 - Verfahren zur herstellung von phenylpiperazinderivaten - Google Patents
Verfahren zur herstellung von phenylpiperazinderivaten Download PDFInfo
- Publication number
- DD202152A5 DD202152A5 DD81233166A DD23316681A DD202152A5 DD 202152 A5 DD202152 A5 DD 202152A5 DD 81233166 A DD81233166 A DD 81233166A DD 23316681 A DD23316681 A DD 23316681A DD 202152 A5 DD202152 A5 DD 202152A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- general formula
- compound
- group
- reacting
- piperazinyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Anesthesiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL8005133A NL8005133A (nl) | 1980-09-12 | 1980-09-12 | Fenylpiperazinederivaten met antiagressieve werking. |
Publications (1)
Publication Number | Publication Date |
---|---|
DD202152A5 true DD202152A5 (de) | 1983-08-31 |
Family
ID=19835870
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD81233166A DD202152A5 (de) | 1980-09-12 | 1981-09-09 | Verfahren zur herstellung von phenylpiperazinderivaten |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0048045A1 (cs) |
JP (1) | JPS5781464A (cs) |
AU (1) | AU7502981A (cs) |
CA (1) | CA1155116A (cs) |
CS (1) | CS228532B2 (cs) |
DD (1) | DD202152A5 (cs) |
DK (1) | DK400081A (cs) |
ES (1) | ES505373A0 (cs) |
FI (1) | FI812808A7 (cs) |
GR (1) | GR75079B (cs) |
HU (1) | HU184966B (cs) |
IL (1) | IL63784A0 (cs) |
NL (1) | NL8005133A (cs) |
PL (1) | PL232965A1 (cs) |
YU (1) | YU217381A (cs) |
ZA (1) | ZA816256B (cs) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA848005B (en) * | 1983-10-17 | 1985-05-29 | Duphar Int Res | Blood-pressure lowering piperazine derivatives |
ATE44528T1 (de) * | 1984-12-21 | 1989-07-15 | Duphar Int Res | Arzneimittel mit antipsychotischer wirkung. |
US4778796A (en) * | 1985-07-19 | 1988-10-18 | Dainippon Pharmaceutical Co., Ltd. | ω-(3-pyridyl)alkenamide derivatives and anti-allergenic pharmaceutical compositions containing same |
US5254552A (en) * | 1988-05-24 | 1993-10-19 | American Home Products Corporation | Aryl-and heteroaryl piperazinyl carboxamides having central nervous system activity |
US5010078A (en) * | 1988-05-24 | 1991-04-23 | American Home Products Corporation | Aryl- and heteroaryl piperazinyl carboxamides having central nervous system activity |
GB8909209D0 (en) * | 1989-04-22 | 1989-06-07 | Wyeth John & Brother Ltd | Piperazine derivatives |
US5192779A (en) * | 1989-02-14 | 1993-03-09 | Fujisawa Pharmaceutical Co., Ltd. | Substituted-acetamide compound and a process for the preparation thereof |
US5066680A (en) * | 1989-02-14 | 1991-11-19 | Fujisawa Pharmaceutical Co., Ltd. | Novel substituted-acetamide compound and a process for the preparation thereof |
US5340812A (en) * | 1989-04-22 | 1994-08-23 | John Wyeth & Brother, Limited | Piperazine derivatives |
DD297968A5 (de) * | 1989-04-22 | 1992-01-30 | �����@��������@�K@�����������@�������k�� | Neue piperazine, ihre herstellung und verwendung in pharmazeutischen mitteln |
US5382583A (en) * | 1989-04-22 | 1995-01-17 | John Wyeth & Brother, Limited | Piperazine derivatives |
DE69033393T2 (de) * | 1989-04-22 | 2000-05-25 | American Home Products Corp., Madison | Tertiäre alkyl funktionalisierte Piperazin-Derivate |
US5939412A (en) * | 1992-06-26 | 1999-08-17 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
JP3497164B2 (ja) * | 1991-06-28 | 2004-02-16 | スミスクライン・ビーチャム・コーポレイション | 二環式フィブリノーゲン拮抗薬 |
GB9200293D0 (en) * | 1992-01-08 | 1992-02-26 | Wyeth John & Brother Ltd | Piperazine derivatives |
SE9201138D0 (sv) * | 1992-04-09 | 1992-04-09 | Astra Ab | Novel phthalimidoalkylpiperazines |
JPH0771521B2 (ja) * | 1992-07-08 | 1995-08-02 | 功司 後藤 | 靴の製法 |
SG63579A1 (en) * | 1992-12-21 | 1999-03-30 | Smithkline Beecham Corp | Bicyclic fibrinogen antagonists |
IT1266582B1 (it) * | 1993-07-30 | 1997-01-09 | Recordati Chem Pharm | Derivati (di)azacicloesanici e diazacicloeptanici |
US6403578B1 (en) | 1993-12-21 | 2002-06-11 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
MA23420A1 (fr) * | 1994-01-07 | 1995-10-01 | Smithkline Beecham Corp | Antagonistes bicycliques de fibrinogene. |
US6458784B1 (en) | 1994-06-29 | 2002-10-01 | Smithkline Beecham Corporation | Vitronectin receptor antagonists |
US5661163A (en) * | 1995-06-07 | 1997-08-26 | Merck & Co., Inc. | Alpha-1a adrenergic receptor antagonists |
US5977101A (en) * | 1995-06-29 | 1999-11-02 | Smithkline Beecham Corporation | Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity |
US5807856A (en) * | 1995-11-15 | 1998-09-15 | Merck & Co., Inc. | Alpha 1a adrenergic receptor antagonist |
AU2393997A (en) * | 1996-04-05 | 1997-10-29 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Alpha1-adrenergic receptor antagonists |
US6451816B1 (en) | 1997-06-20 | 2002-09-17 | Klinge Pharma Gmbh | Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression |
DE19624704A1 (de) * | 1996-06-20 | 1998-01-08 | Klinge Co Chem Pharm Fab | Neue Pyridylalkansäureamide |
DE19624659A1 (de) | 1996-06-20 | 1998-01-08 | Klinge Co Chem Pharm Fab | Neue Pyridylalken- und Pyridylalkinsäureamide |
DE19756235A1 (de) | 1997-12-17 | 1999-07-01 | Klinge Co Chem Pharm Fab | Neue piperidinylsubstituierte Pyridylalkan- alken- und -alkincarbonsäureamide |
DE19756212A1 (de) | 1997-12-17 | 1999-07-01 | Klinge Co Chem Pharm Fab | Neue, mit einem cyclischen Imid substituierte Pyridylalkan-, alken- und -alkincarbonsäureamide |
DE19756261A1 (de) | 1997-12-17 | 1999-07-01 | Klinge Co Chem Pharm Fab | Neue arylsubstituierte Pyridylalkan-, alken- und alkincarbonsäureamide |
US6903118B1 (en) | 1997-12-17 | 2005-06-07 | Klinge Pharma Gmbh | Piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides |
DE19756236A1 (de) * | 1997-12-17 | 1999-07-01 | Klinge Co Chem Pharm Fab | Neue piperazinylsubstituierte Pyridylalkan-, alken- und -alkincarbonsäureamide |
EP1031564A1 (en) | 1999-02-26 | 2000-08-30 | Klinge Pharma GmbH | Inhibitors of cellular nicotinamide mononucleotide formation and their use in cancer therapy |
AU2003235442A1 (en) * | 2002-04-12 | 2003-10-27 | Sepracor, Inc. | 3-aza- and 1,4-diaza-bicyclo(4.3.0)nonanes, and methods of use thereof |
DE50306588D1 (de) * | 2002-07-04 | 2007-04-05 | Sanol Arznei Schwarz Gmbh | Heteroarencarboxamide zur verwendung als dopamin-d3 liganden zur behandlung von zns-erkrankungen |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1088058B (de) * | 1956-08-21 | 1960-09-01 | Davis & Company | Verfahren zur Herstellung von sympatholytisch wirkenden N-o-Halogenphenyl-N'-acylamino-alkylpiperazinen und deren Saeuresalzen |
GB1166364A (en) * | 1966-11-25 | 1969-10-08 | American Cyanamid Co | N-(Tert-Aminoalkyl) Amide Derivatives and Process for Preparing the Same |
BE788280A (fr) * | 1971-09-04 | 1973-02-28 | Pfizer | Nouvelles 1-(3-trifluoro-methyl-phenyl)-4-((amido cyclique)- alkyl) piperazines et composition pharmaceutique les contenant |
AU532411B2 (en) * | 1979-03-01 | 1983-09-29 | Duphar International Research B.V. | Phenyl piperazine derivatives |
-
1980
- 1980-09-12 NL NL8005133A patent/NL8005133A/nl not_active Application Discontinuation
-
1981
- 1981-08-25 EP EP81200929A patent/EP0048045A1/en not_active Withdrawn
- 1981-09-08 AU AU75029/81A patent/AU7502981A/en not_active Abandoned
- 1981-09-08 GR GR66001A patent/GR75079B/el unknown
- 1981-09-08 HU HU812582A patent/HU184966B/hu unknown
- 1981-09-09 JP JP56141150A patent/JPS5781464A/ja active Pending
- 1981-09-09 FI FI812808A patent/FI812808A7/fi not_active Application Discontinuation
- 1981-09-09 CS CS816656A patent/CS228532B2/cs unknown
- 1981-09-09 DD DD81233166A patent/DD202152A5/de unknown
- 1981-09-09 ZA ZA816256A patent/ZA816256B/xx unknown
- 1981-09-09 YU YU02173/81A patent/YU217381A/xx unknown
- 1981-09-09 IL IL63784A patent/IL63784A0/xx unknown
- 1981-09-09 PL PL23296581A patent/PL232965A1/xx unknown
- 1981-09-09 DK DK400081A patent/DK400081A/da not_active Application Discontinuation
- 1981-09-10 ES ES505373A patent/ES505373A0/es active Granted
- 1981-09-11 CA CA000385649A patent/CA1155116A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
IL63784A0 (en) | 1981-12-31 |
YU217381A (en) | 1983-09-30 |
DK400081A (da) | 1982-03-13 |
ES8302681A1 (es) | 1982-12-01 |
FI812808L (fi) | 1982-03-13 |
HU184966B (en) | 1984-11-28 |
PL232965A1 (cs) | 1982-10-25 |
NL8005133A (nl) | 1982-04-01 |
ZA816256B (en) | 1982-08-25 |
CS228532B2 (en) | 1984-05-14 |
GR75079B (cs) | 1984-07-13 |
FI812808A7 (fi) | 1982-03-13 |
JPS5781464A (en) | 1982-05-21 |
CA1155116A (en) | 1983-10-11 |
AU7502981A (en) | 1982-03-18 |
ES505373A0 (es) | 1982-12-01 |
EP0048045A1 (en) | 1982-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DD202152A5 (de) | Verfahren zur herstellung von phenylpiperazinderivaten | |
AT363096B (de) | Verfahren zur herstellung von neuen phthalazinderivaten und deren salzen | |
DE1620262C3 (de) | Spiro [4.5] decanderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen | |
EP0726899B1 (de) | Neue pyrazincarboxamidderivate, ihre herstellung und ihre verwendung in arzneimitteln | |
DE2105490A1 (de) | Imidazolderivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel | |
DE2205815A1 (de) | Piperazinderivate und verfahren zu ihrer herstellung | |
DD251973A5 (de) | Verfahren zur herstellung von 3(2h)-pyridazinon-derivaten | |
DE3686245T2 (de) | Amidderivate und antiallergische mittel, die sie enthalten. | |
EP0090369B1 (de) | Salicylsäurederivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen und ihre Verwendung | |
EP0018360B1 (de) | N-(5-Methoxybentofuran-2-ylcarbonyl)-N'-benzylpiperazin und Verfahren zu dessen Herstellung | |
DD270305A5 (de) | Verfahren zur herstellung von neuen benzofuron-2-yl-imidozol-derivaten | |
DE3027106C2 (cs) | ||
DE69110217T2 (de) | Derivate der Kaffeinsäure und sie enthaltende pharmazeutische Zusammensetzungen. | |
DE3305495A1 (de) | Piperazin- und homopiperazinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen | |
DE3113087C2 (de) | 1,4-Disubstituierte Piperazine, deren Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
DE2012667C3 (de) | 3- (4-substituierte-1-Piperazinyl)-carbonylmethyl-2-benzothiazolinone und ihre Säureadditionssalze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharamazeutische Präparate | |
DE2903917C2 (cs) | ||
DE2636866A1 (de) | Neue phenothiazinderivate und deren herstellung | |
DE2735589A1 (de) | 1-phenyl-1-methoxy-2-amino-aethan- derivate und verfahren zu ihrer herstellung | |
DE2629756C2 (cs) | ||
DE3204074C2 (cs) | ||
DE2166270B2 (de) | Nicotinoylaminoäthansulfonyl-2amino-thiazol | |
DD202288A5 (de) | Verfahren zur herstellung von phenylpiperazinderivaten | |
AT281812B (de) | Verfahren zur herstellung von neuen 2,3-dihydrobenzofuranderivaten und ihren salzen | |
DE2062055A1 (de) | Propanolamin Derivate |